Trial for the world-first lung cancer vaccine has begun in the UK. This is being hailed as a "groundbreaking" advance because it is highly targeted. BNT116 vaccine specifically targets cancer cells for destruction and hopes to leave healthy cells untouched. This means that it can reduce the side-effects of cancer treatment. So can the vaccine save millions of lives? Palki Sharma brings you the report.